(Credit-Canva)
When something is going wrong in your body, there will be signs. They may be subtle, but they are visible in close observation. If you are a smoker, you may be worried about the smell of smoke emanating from your mouth or clothes. However, there are other signs that tell whether you smoke or not and these signs are difficult to get rid of!
Smoking is the harmful act of inhaling tobacco infused smoke and is a common activity all over the world. According to the Center of Disease Control and Prevention (CDC), over 480,000 deaths happen each year due to smoking or smoke inhalation. The organization explained that smoking causes harm to nearly all organs and quitting lowers the risk of early death and other smoking related diseases.
Like many other substances, there are clear tell-tale signs when someone is smoking. This is especially important for finding lung problems like Chronic obstructive pulmonary disease (COPD), which is a lung disease that makes it hard to breathe, sooner so people can get help.
Action on Smoking and Health (ASH) explains that tobacco smoke has more than 7,000 harmful chemicals like nicotine, carbon monoxide, and various metals like arsenic, cadmium, and lead, quickly reach your lungs and then travel through your blood to all your organs, including your skin. Smoking damages your skin's ability to heal because it increases an enzyme metalloproteinase (MMPs) that breaks down collagen. Collagen is what keeps your skin smooth and elastic. As you lose collagen, your skin sags. Squinting from the smoke and puckering your mouth when smoking also cause wrinkles around your eyes and mouth.
Smoking also reduces blood flow to your skin, which means it gets less oxygen and nutrients. All these things together lead to what doctors call a "smoker's face." Quitting smoking can help prevent or slow down these skin problems."
Here are some visible signs of smoking in people, according to 2013, Lung India
When people smoke, the tar and other chemicals in the smoke stick to their fingers and nails. This repeated contact causes a yellow stain that's hard to wash off. It's a very common sign that someone regularly handles cigarettes or biris.
Especially in older people with white moustaches, smoking causes a yellowing effect. This is most noticeable in the center of the moustache, where the smoke from the nose directly hits the hair. The consistent exposure to smoke colors the hair over time.
Heavy smokers often have a bluish-black tint to their lips. This discoloration happens because the chemicals in tobacco smoke affect the blood flow and the color of the skin on the lips. The constant exposure changes the lip's natural color.
Smoking causes teeth to stain both inside and out. The outside of the teeth turns yellow from the tar, while the inside develops a brownish-black stain. This happens because the smoke seeps into the enamel and discolors the teeth over time.
Smoking makes the skin age faster. This leads to wrinkles like "crow's feet" around the eyes and "cobblestone wrinkles" on the neck. This happens because smoking reduces blood flow, limiting oxygen to the skin, and damages collagen, which keeps skin elastic.
This condition, also known as "Favre–Racouchot syndrome," causes blackheads and wrinkles, especially around the eyes and temples. It is made worse by both sun exposure and heavy smoking. The skin becomes discolored with visible nodules and wrinkles.
A study published in Thorax 2006 found a connection between wrinkles on the face and COPD, a lung disease. It's thought that smoking affects both the skin and lungs through similar processes. If doctors notice signs like "crow's feet" on a smoker's face, they might recommend tests for COPD. This early detection can help people get treatment sooner and improve their lung health.
Credit: iStock
Menopause typically occurs between the ages of 45 and 55. However, the hormonal changes leading up to it can begin earlier, with some women reporting symptoms in their 30s.
A 2025 study published in NPJ Women's Health examined 4,400 American women aged 30 and older. It found that roughly 55% of women aged 30-35 reported moderate or severe symptoms on the Menopause Rating Scale. The proportion rose to just over 64% among women aged 36-40. Despite these symptoms, most women did not seek treatment until they were 56 or older.
Speaking to HealthandMe, Dr. Kajal Parikh is an Obstetrician and a Gynecologist based in Mumbai, explained how hormonal changes can begin in the mid-to-late 30s, the signs women should watch for, and why monitoring symptoms and maintaining healthy habits matter during this transition.
From the first menstrual period to menopause, the body undergoes significant hormonal changes. Estrogen and progesterone are among the hormones involved in this process.
“These hormones don't exit overnight. The exit starts much earlier. Starting mid-30s to late 30s, the hormone levels start depleting. Now, when that level starts depleting, you're going to see signals.”
According to Dr Parikh, changes in menstrual cycles can be among the first signs. Periods may become heavier or lighter, while cycles may become shorter or longer.
Being mindful of these changes can help women identify patterns and discuss persistent or concerning symptoms with a healthcare professional. However, these symptoms alone do not confirm that a woman is in perimenopause.
Also read: Menopause Abruptly Shifts Bones, Liver And Blood Fats, Study Finds
Perimenopause symptoms can extend beyond menstrual changes. Women may notice dry skin, pigmentation, hair thinning, increased hair fall, low energy, brain fog and disturbed sleep.
Some women who previously slept well may begin waking up at 3 or 4 a.m. and find it difficult to return to sleep, Dr Parikh told HealthandMe.
“That's your body asking for some help, or rather the body signaling that we are going through some crisis, see how we can fix it.”
Other possible symptoms include breast tenderness, worsening premenstrual symptoms, headaches, migraines, and bone and joint pain. Vaginal dryness, changes in urinary habits and reduced libido may also occur.
Symptoms vary considerably between individuals, and many of these changes can have causes other than perimenopause, the expert said,
Read More: ‘I Was Vocal About Cancer But Silent About Menopause Out Of Shame’, Says Actress Lisa Ray
Dr Parikh recommended annual gynecological visits to monitor changes over time. She also advised women to track their symptoms and seek medical advice if they worsen or do not improve with treatment.
Although menstrual changes may become noticeable in the late 30s and early 40s, the timing of the menopausal transition varies. Some women experience menopause earlier than expected, while others continue menstruating into their 50s.
For women without symptoms, Dr Parikh identified 40 as an appropriate age to begin regular monitoring and annual screening.
“40 is that golden age when you start monitoring, when you start getting your annual screenings done.”
The need for specific tests depends on a woman's age, symptoms and medical history. Women experiencing menstrual changes or possible menopausal symptoms at a younger age should consult a healthcare professional rather than waiting until 40.
Dr Parikh said doctors may assess iron levels, thyroid function, blood sugar and lipid levels while reviewing a woman's diet, nutrition and exercise habits. These assessments can help identify other conditions that may contribute to symptoms.
She also emphasised the importance of sleep, nutrition and exercise during the menopausal transition.
“The only thing that will save you from this transition are your three strong pillars, which is your sleep, your nutrition, and your exercise regimen.”
Treatment depends on the symptoms and individual health needs. After assessing symptoms and ruling out other possible causes, doctors can discuss appropriate options, including hormone therapy when indicated.
READ: Can Menopause Be Delayed? What Science Says About Slowing Ovarian Aging
Dr Parikh said genetics can play a role in determining when menopause occurs. A family history of early menopause, including in a woman's mother or grandmother, may be relevant when discussing her own reproductive health.
She also raised concerns about potential environmental exposures, including endocrine-disrupting chemicals found in some products and packaging. However, their individual contribution to the timing of menopause is difficult to establish, and these exposures should not be presented as proven causes of early menopause.
Maintaining a balanced diet, exercising regularly and prioritising sleep can support overall health during the menopausal transition.
Credit: iStock
For a patient with advanced heart failure, there comes a point when medicines, devices and repeated hospitalisations can no longer control the disease. For some, a heart transplant may offer the only realistic path to long-term survival. Yet in India, the challenge often begins much earlier than the waiting list: many patients who could potentially benefit from transplantation never reach an advanced heart-failure or transplant centre for evaluation.
The scale of the problem is enormous. A recent study found that 83,000 heart transplantations were required annually in India in 2021, although only a very small proportion of that need was met. In comparison, according to the National Organ and Tissue Transplant Organisation (NOTTO), 221 heart transplants were performed in 2023.
The first issue is delayed referral. Patients with advanced heart failure may continue to be treated repeatedly for breathlessness, fluid retention or hospital admissions without being assessed early for advanced therapies.
A transplant evaluation is not a last-minute decision. It requires time to assess the patient's medical condition, other organs, infection risk, nutrition, psychosocial circumstances and ability to undergo lifelong follow-up.
The second challenge is the limited availability of donor hearts. Heart transplantation depends almost entirely on deceased organ donation. India has made substantial progress in transplantation overall, but the national deceased organ donation rate remains less than one donor per million population.
Geography and affordability also matter. Advanced heart-failure programmes and transplant centres are concentrated in selected regions, meaning that patients from smaller cities and rural areas may face substantial travel, financial and logistical barriers.
The cost of evaluation, repeated hospitalisations, mechanical circulatory support and post-transplant medicines can further influence whether a patient can realistically pursue transplantation.
We therefore need to change the way advanced heart failure is recognised. A patient with recurrent hospitalisations, persistent symptoms despite optimal therapy, progressive kidney or liver dysfunction, low blood pressure limiting medications, or dependence on intravenous therapies should trigger consideration of referral to an advanced heart-failure centre.
Early referral gives specialists more time to evaluate the patient, assess treatment options and determine whether transplantation or another advanced therapy is appropriate.
Importantly, transplantation is not the only advanced therapy. Left ventricular assist devices (LVADs) can serve as a bridge to transplantation or, in selected patients, as long-term therapy.
These devices can help support the heart's pumping function in patients with advanced heart failure who meet the criteria for their use. The appropriate option depends on the patient's condition, overall health and treatment goals.
India has demonstrated that transplantation can grow rapidly when infrastructure, coordination and public awareness improve. The next step is to ensure that patients are identified early enough to be evaluated, and that a shortage of donor organs does not remain the only reason they never get the opportunity to reach the transplant list.
By Dr. Pravin Kulkarni, MBBS, MS (General Surgery), MCh (Cardiovascular and Thoracic Surgery), Fellowship in CTS, Director, Advanced Cardiac Surgery and Heart and Lung Transplant Program
Credit: iStock
According to the latest National Family Health Survey (NFHS-6), 30.7% of women aged 15-49 years in India are reported as overweight or obese, highlighting the growing importance of lifestyle factors in women’s reproductive and overall health. Along with nutrition and physical activity, sleep is another important factor for overall menstrual health and the ovulation cycle.
Ovulation is controlled by a complex interaction between the brain, pituitary gland and ovaries. This reproductive hormone system is closely connected to the body's circadian rhythm, which regulates the sleep-wake cycle and influences the timing of several hormonal processes. When sleep becomes consistently irregular or insufficient, these signals may become disrupted, potentially affecting the hormonal coordination required for normal ovulation.
Also read: Andrew Huberman’s Sleep Trick: Can Eye Movements Help You Fall Back Asleep?
One of the ways this may occur is through interference with the functioning of the hypothalamic-pituitary-adrenal (HPA) axis. The reproductive system relies on communication between the hypothalamus and pituitary gland to regulate the hormones involved in follicle development and egg release.
Melatonin is another hormone linked to sleep and circadian rhythm. It also has antioxidant properties in the ovaries. This is why the relationship between sleep and fertility may involve more than simply the number of hours a woman sleeps.
A 2025 study published in Chronobiology International found that a later chronotype, or a tendency to sleep and wake later, was associated with a higher risk of sporadic anovulation among women with regular menstrual cycles.
Each one-hour increase in later chronotype was associated with a 5% higher relative risk of anovulation (RR 1.05; 95% CI 1.00–1.11), while women in the third chronotype tertile had a 33% higher relative risk compared with those in the second tertile (RR 1.33; 95% CI 1.05–1.68).
Interestingly, sleep duration itself was not associated with anovulation, suggesting that sleep timing and circadian patterns may also matter.
Sleep may also be relevant during fertility treatment. A 2025 prospective cohort study of 174 women undergoing IVF/ICSI reported that women with poor sleep quality had 22.89% fewer retrieved oocytes and 22.01% fewer matured oocytes after adjustment for relevant factors.
The study also reported associations between certain sleep patterns and other IVF outcomes. However, these findings are observational and do not establish that poor sleep directly causes poorer fertility outcomes.
© $2026 Times Horizon Private Limited